[Relevance of clinical trials for the decision-making process within the bodies of the self-government].
Clinical studies are the central basis on which the decision-making process regarding reimbursement of medical interventions of the bodies of the self-government is founded. For many of these reimbursement questions that await a decision, studies with a sufficient certainty of results are absent. Even though the self-government has instruments on hand with which it may initiate clinical trials (i.e. the deferment of a decision of the Federal Joint Committee) or support them (German Social Code, Book V,§ 35c), the possibilities of a remedy of this deficit itself are limited. A continuous and sound advancement and funding of the development of structures that lead to the conduct of the required clinical trials, independently of particular interests (e.g. of the pharmaceutical industry), is urgently needed.